<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Abbott Laboratories,1888,1894,1900,1906,1910,1916,1920,1923,1929,1930" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Abbott Laboratories - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Abbott Laboratories</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table class="infobox" style="width:23em; font-size:90%;">
<tr>
<td colspan="2" style="text-align: center; font-size:larger;"><b>Abbott Laboratories</b></td>
</tr>
<tr>
<td colspan="2" style="text-align:center; padding:16px 0 16px 0;"><a href="../../../a/b/b/Image%7EAbbott.gif_fe86.html" class="image" title="Image:Abbott.gif"><img src="../../../upload/3/30/Abbott.gif" alt="Image:Abbott.gif" width="230" height="94" longdesc="../../../a/b/b/Image%7EAbbott.gif_fe86.html" /></a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../t/y/p/Category%7ETypes_of_companies_064c.html" title="Category:Types of companies">Type</a></th>
<td><a href="../../../p/u/b/Public_company.html" title="Public company">Public</a> (<a href="../../../n/e/w/New_York_Stock_Exchange_a4c5.html" title="New York Stock Exchange">NYSE</a>: <a href="http://www.nyse.com/about/listed/lcddata.html?ticker=ABT" class="external text" title="http://www.nyse.com/about/listed/lcddata.html?ticker=ABT" rel="nofollow">ABT</a>)</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;">Founded</th>
<td><a href="../../../1/8/8/1888.html" title="1888">1888</a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;">Headquarters</th>
<td>Abbott Park, North Chicago, Illinois, USA</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;">Key&#160;people</th>
<td><a href="../../../m/i/l/Miles_D._White_01c4.html" title="Miles D. White">Miles D. White</a>, Chairman and CEO<br />
Richard A. Gonzalez, Medical Products Group<br />
President &amp; COO<br /></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../p/r/o/Product_%28business%29.html" title="Product (business)">Products</a></th>
<td>Human and Veterinary pharmaceutical products, diagnostic assays and Nutritional Products</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../e/m/p/Employment.html" title="Employment">Employees</a></th>
<td>&gt; 60,600</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../s/l/o/Slogan.html" title="Slogan">Slogan</a></th>
<td>A promise for life</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../w/e/b/Website.html" title="Website">Website</a></th>
<td><a href="http://www.abbott.com/" class="external text" title="http://www.abbott.com/" rel="nofollow">www.abbott.com/</a></td>
</tr>
</table>
<p><b>Abbott Laboratories</b> (<a href="../../../n/e/w/New_York_Stock_Exchange_a4c5.html" title="New York Stock Exchange">NYSE</a>: <a href="http://www.nyse.com/about/listed/lcddata.html?ticker=ABT" class="external text" title="http://www.nyse.com/about/listed/lcddata.html?ticker=ABT" rel="nofollow">ABT</a>) is a diversified <a href="../../../p/h/a/Pharmacology.html" title="Pharmacology">pharmaceuticals</a> and <a href="../../../h/e/a/Health_care.html" title="Health care">health care</a> company. It has over 60,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, <a href="../../../i/l/l/Illinois.html" title="Illinois">Illinois</a>, a northern suburb of <a href="../../../c/h/i/Chicago.html" title="Chicago">Chicago</a>, near its manufacturing center in <a href="../../../n/o/r/North_Chicago%2C_Illinois_7b17.html" title="North Chicago, Illinois">North Chicago, Illinois</a>.</p>
<p>Abbott Laboratories was founded by Chicago physician Wallace Calvin Abbott in 1888. In <a href="../../../2/0/0/2003.html" title="2003">2003</a>, Abbott had nearly $20 billion in sales.</p>
<p>In 1985, the company developed the first <a href="../../../h/i/v/HIV_abc5.html" title="HIV">HIV</a> blood screening test. The company's drug portfolio includes <i><a href="../../../h/u/m/Humira.html" title="Humira">Humira</a></i>, a drug for <a href="../../../r/h/e/Rheumatoid_arthritis.html" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <i><a href="../../../n/o/r/Norvir.html" title="Norvir">Norvir</a></i>, a treatment for HIV, <i><a href="../../../d/e/p/Depakote.html" title="Depakote">Depakote</a></i>, an <a href="../../../a/n/t/Anticonvulsant.html" title="Anticonvulsant">anticonvulsant</a> drug, and <i><a href="../../../s/y/n/Synthroid.html" title="Synthroid">Synthroid</a></i>, a synthetic <a href="../../../t/h/y/Thyroid_hormone.html" title="Thyroid hormone">thyroid hormone</a>. Abbott also has a broad range of diagnostics and <a href="../../../i/m/m/Immunoassay.html" title="Immunoassay">immunoassay</a> products as well as <i><a href="../../../e/n/s/Ensure.html" title="Ensure">Ensure</a></i>, a line of well known meal replacement shakes.</p>
<p>Abbott’s in vitro diagnostics business is a world leader in immunoassays and blood screening. Abbott’s broad range of medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other important indicators of general health.</p>
<p>Abbott Point-of-Care manufactures diagnostic products for blood analysis to provide health care professionals critical diagnostics information accurately and immediately at the point of patient care. In addition to its offerings in the blood gas and chemistries segment, Abbott also provides point-of-care cardiac assays to the emergency room.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Organization"><span class="tocnumber">1</span> <span class="toctext">Organization</span></a></li>
<li class="toclevel-1"><a href="#Products"><span class="tocnumber">2</span> <span class="toctext">Products</span></a></li>
<li class="toclevel-1"><a href="#Controversies"><span class="tocnumber">3</span> <span class="toctext">Controversies</span></a>
<ul>
<li class="toclevel-2"><a href="#Access_to_Kaletra"><span class="tocnumber">3.1</span> <span class="toctext">Access to Kaletra</span></a></li>
<li class="toclevel-2"><a href="#Pricing_of_Norvir"><span class="tocnumber">3.2</span> <span class="toctext">Pricing of Norvir</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Timeline"><span class="tocnumber">4</span> <span class="toctext">Timeline</span></a></li>
<li class="toclevel-1"><a href="#Awards"><span class="tocnumber">5</span> <span class="toctext">Awards</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">6</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Organization" id="Organization"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Organization">edit</a>]</span> <span class="mw-headline">Organization</span></h2>
<p>Abbott's core businesses in the pharmaceutical and biomedical industries is organized into major divisions, which have recently been supplemented through several notable acquisitions. It has also divested itself of less profitable businesses through sales and spinoffs. Abbott's principal divisions include Global Pharmaceutical Research and Development (GPRD) and Abbott Diagnostics Division (ADD).</p>
<p>In <a href="../../../2/0/0/2001.html" title="2001">2001</a>, Abbott acquired Knoll, the phamaceutical division of <a href="../../../b/a/s/BASF_1672.html" title="BASF">BASF</a>.</p>
<p>In <a href="../../../2/0/0/2004.html" title="2004">2004</a>, Abbott spun off its hospital products division into a new 14,000 employee company named <a href="../../../h/o/s/Hospira.html" title="Hospira">Hospira</a>, and acquired TheraSense, a <a href="../../../d/i/a/Diabetes.html" title="Diabetes">diabetes</a> care company, which it merged with its MediSense division to become Abbott Diabetes Care. In <a href="../../../2/0/0/2006.html" title="2006">2006</a>, Abbott assisted <a href="../../../b/o/s/Boston_Scientific_ade4.html" title="Boston Scientific">Boston Scientific</a> in its purchase of <a href="../../../g/u/i/Guidant.html" title="Guidant">Guidant</a> Corporation. As part of the agreement, Abbott purchased the vascular device division of Guidant.</p>
<p>In January 2007, <strong class="selflink">Abbott Laboratories</strong> agreed to sell its in vitro diagnostics and Point-of-Care diagnostics divisions to <a href="../../../g/e/n/General_Electric_4bb6.html" title="General Electric">General Electric</a> for more than $8 billion. These units are slated to be integrated into the <a href="../../../g/e/_/GE_Healthcare_cb87.html" title="GE Healthcare">GE Healthcare</a> business unit. The transaction, which is subject to regulatory approvals and other customary conditions, has been approved by the Boards of Directors of Abbott and GE and is targeted to close in the first half of 2007.</p>
<p><a name="Products" id="Products"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Products">edit</a>]</span> <span class="mw-headline">Products</span></h2>
<p>Some of the key products produced by Abbott Laboratories, circa 2006, include:</p>
<ul>
<li>Similac-LF (Infant milk powder Lactose free)</li>
<li>Biaxin/Klacid (<a href="../../../c/l/a/Clarithromycin.html" title="Clarithromycin">clarithromycin</a>)</li>
<li>Depacon (<a href="../../../v/a/l/Valproic_acid.html" title="Valproic acid">valproic acid</a>)</li>
<li>Depakote (<a href="../../../v/a/l/Valproate_semisodium.html" title="Valproate semisodium">valproate semisodium</a>)</li>
<li>Freestyle Freedom blood glucose monitor</li>
<li>Freestyle Flash blood glucose monitor</li>
<li>Gengraf (<a href="../../../c/y/c/Cyclosporin.html" title="Cyclosporin">cyclosporin</a>)</li>
<li>Gopten/Mavik (<a href="../../../t/r/a/Trandolapril.html" title="Trandolapril">trandolapril</a>)</li>
<li>Humira (<a href="../../../a/d/a/Adalimumab.html" title="Adalimumab">adalimumab</a>)</li>
<li>Isoptin (<a href="../../../v/e/r/Verapamil.html" title="Verapamil">verapamil</a>)</li>
<li>Hytrin (<a href="../../../t/e/r/Terazosin.html" title="Terazosin">terazosin</a>)</li>
<li>Kaletra (lopinavir/ritonavir)</li>
<li>Meridia/Reductil (<a href="../../../s/i/b/Sibutramine.html" title="Sibutramine">sibutramine</a>)</li>
<li>Norvir (<a href="../../../r/i/t/Ritonavir.html" title="Ritonavir">ritonavir</a>)</li>
<li>Omnicef (<a href="../../../c/e/f/Cefdinir.html" title="Cefdinir">cefdinir</a>)</li>
<li>Synthroid (<a href="../../../l/e/v/Levothyroxine.html" title="Levothyroxine">levothyroxine</a>)</li>
<li>Tarka (trandolapril/verapamil)</li>
<li>Tricor (<a href="../../../f/e/n/Fenofibrate.html" title="Fenofibrate">fenofibrate</a>)</li>
<li>Ultane (<a href="../../../s/e/v/Sevoflurane.html" title="Sevoflurane">sevoflurane</a>)</li>
<li>cell-dyn 1400 analyzer (<a href="../../../f/u/l/Full_blood_count.html" title="Full blood count">full blood count</a>)</li>
</ul>
<p><a name="Controversies" id="Controversies"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Controversies">edit</a>]</span> <span class="mw-headline">Controversies</span></h2>
<p><a name="Access_to_Kaletra" id="Access_to_Kaletra"></a></p>
<h3><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Access to Kaletra">edit</a>]</span> <span class="mw-headline">Access to Kaletra</span></h3>
<p>In 2006, protesters from many organizations, including <a href="../../../d/o/c/Doctors_Without_Borders_ba8d.html" title="Doctors Without Borders">Doctors Without Borders</a>, the <a href="../../../s/t/u/Student_Global_AIDS_Campaign_1e2b.html" title="Student Global AIDS Campaign">Student Global AIDS Campaign</a>, and <a href="../../../a/i/d/AIDS_Coalition_to_Unleash_Power_6627.html" title="AIDS Coalition to Unleash Power">Act Up</a>, have held protests at Abbott's offices and laboratories across the US (including in Illinois, Virginia, New Jersey, and Florida), demanding that Abbott actively take part in registering Kaletra in developing countries, to create affordable prices in <a href="../../../m/i/d/Middle_class.html" title="Middle class">middle-income</a> countries, to establish a <a href="../../../p/e/d/Pediatrics.html" title="Pediatrics">pediatric</a> version of the drug, and to create open licenses to allow for <a href="../../../g/e/n/Generic_drug.html" title="Generic drug">generic drugs</a> to be made for those areas the company labels as 'unprofitable'. To their credit, Abbott executives have recently developed plans to register the new version of Kaletra in <a href="../../../s/o/u/South_Africa_1287.html" title="South Africa">South Africa</a>. The activists still expressed concern about the year and a half deadline for fully registering the drugs, worrying about the millions of people that will hang in the balance until then. In addition, the activists stated that they desired more <a href="../../../h/o/l/Holism.html" title="Holism">holistic</a> approaches from Abbott, and response to demands for expanded programs in one country. Most recently, <a href="../../../s/h/a/Shareholder.html" title="Shareholder">stockholders</a> have expressed some unease about the protests, pointing to anxiety in activists continuing to protest even after Abbott voiced their plans for registration of Kaletra in South Africa.</p>
<p>In March 2007, Abbott announced it will not be introducing any new medicines into Thailand, because Thailand had decided to use generic Kaletra. Thailand, a country with a per capita income of about $2742, had recently issued WTO-compliant compulsory licenses to allow government use of this drug and efavirenz for treatment of the estimated 600,000 people living with HIV/AIDS in that country.<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since March 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p><a name="Pricing_of_Norvir" id="Pricing_of_Norvir"></a></p>
<h3><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Pricing of Norvir">edit</a>]</span> <span class="mw-headline">Pricing of Norvir</span></h3>
<p>Abbott caused controversy in <a href="../../../2/0/0/2003.html" title="2003">2003</a> over a sharp rise in price of Norvir treatment from $1.71 per day to $8.57 per day, spurring claims of <a href="../../../p/r/i/Price_gouging.html" title="Price gouging">price gouging</a> by consumer groups and some members of Congress. Critics point out that Abbott received $3,500,000 in grants from the <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a> taxpayers to develop Norvir, although the company has responded by pointing out the nearly $200 million development cost for the drug.</p>
<p>Consumer rights group Essential Inventions petitioned the <a href="../../../n/a/t/National_Institutes_of_Health_5b2b.html" title="National Institutes of Health">National Institutes of Health</a> to override Abbott's patent on Norvir, but the agency refused to do so on <a href="../../../a/u/g/August_4.html" title="August 4">August 4</a>, <a href="../../../2/0/0/2004.html" title="2004">2004</a>, citing potential widespread adverse effects on the <a href="../../../p/h/a/Pharmaceutical.html" title="Pharmaceutical">pharmaceutical</a> market.</p>
<p><a name="Timeline" id="Timeline"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Timeline">edit</a>]</span> <span class="mw-headline">Timeline</span></h2>
<ul>
<li><a href="../../../1/8/8/1888.html" title="1888">1888</a> Dr. Wallace C. Abbott, a practicing physician, begins manufacturing dosimetric granules. Dr. Abbott is one of the founders of modern pharmacy.</li>
<li><a href="../../../1/8/9/1894.html" title="1894">1894</a> Dr. Abbott acquires and becomes editor of The Alkaloidal Clinic.</li>
<li><a href="../../../1/9/0/1900.html" title="1900">1900</a> The company is officially incorporated as the Abbott Alkaloidal Company.</li>
<li><a href="../../../1/9/0/1906.html" title="1906">1906</a> To reach more physicians, Dr. Abbott establishes the company’s sales force.</li>
<li><a href="../../../1/9/1/1910.html" title="1910">1910</a> Abbott establishes its first European agency in London and branches in New York, San Francisco, Seattle, Toronto and India.</li>
<li><a href="../../../1/9/1/1916.html" title="1916">1916</a> Abbott acquires its first synthetic medicine, an antiseptic agent called Chlorazene, which is used extensively on the battlefields of World War I to clean wounds.</li>
<li><a href="../../../1/9/2/1920.html" title="1920">1920</a> Dr. Abbott breaks ground for a new facility in North Chicago, Illinois. The site serves as the company’s world headquarters for more than 40 years.</li>
<li><a href="../../../1/9/2/1923.html" title="1923">1923</a> Abbott develops the synthetic drug Butyn, a local anesthetic, based on butyl alcohol. It marks Abbott’s official entrance into the anesthesia market, and butyl alcohol becomes a keystone of Abbott's scientific research in sleep-inducing agents.</li>
<li><a href="../../../1/9/2/1929.html" title="1929">1929</a> Abbott stock is listed on the Chicago Stock Exchange with an offering of 20,000 shares at $32 each.</li>
<li><a href="../../../1/9/3/1930.html" title="1930">1930</a> Nembutal, a sedative - hypnotic agent and one of Abbott's best-known and longest-lived products, is introduced.</li>
<li><a href="../../../1/9/3/1931.html" title="1931">1931</a> Combining an existing sales office and the Canadian operations of the recently acquired Swan Meyer, Co., Abbott establishes its first international affiliate in Montreal, Canada.</li>
<li><a href="../../../1/9/3/1936.html" title="1936">1936</a> Abbott introduces Pentothal (thiopental sodium), which will be the most widely used induction anesthetic in the world for more than 50 years. Abbott enters the I.V. business by supplying hospitals with bulk intravenous solutions.</li>
<li><a href="../../../1/9/3/1938.html" title="1938">1938</a> Abbott celebrates its 50th anniversary with the dedication of its North Chicago Research Center.</li>
<li><a href="../../../1/9/3/1939.html" title="1939">1939</a> Health care benefits are extended to employees' dependents.</li>
<li><a href="../../../1/9/4/1941.html" title="1941">1941</a> Discovered in Great Britain in 1928, penicillin had tremendous clinical value, but had yet to be produced on a large scale. In 1941, Britain seeks help in starting large-scale production and Abbott accepts the challenge. Within three months Abbott begins commercial production of penicillin, one of the five pioneers in the United States.</li>
<li><a href="../../../1/9/4/1942.html" title="1942">1942</a> Abbott introduces Halazone, a water purification tablet shipped by the millions to every fighting front in World War II.</li>
<li><a href="../../../1/9/4/1943.html" title="1943">1943</a> Abbott opens its first facility in Puerto Rico, later to become one of its largest manufacturing operations.</li>
<li><a href="../../../1/9/4/1945.html" title="1945">1945</a> Abbott introduces Tridione for treatment of epilepsy, Surbex, a high-potency vitamin, and Venopac, the first fully disposable intravenous administration set.</li>
<li><a href="../../../1/9/4/1946.html" title="1946">1946</a> Abbott is the first pharmaceutical company to have a special laboratory for radioactive pharmaceuticals, or "radiopharmaceuticals," a move that leads to the creation of what will become the world’s leading immunodiagnostics business.</li>
<li><a href="../../../1/9/4/1947.html" title="1947">1947</a> Abbott introduces Aminosol, a new protein solution for intravenous feeding of surgical patients. Abbott develops the Abbott Sanitary Counting Tray.</li>
<li><a href="../../../1/9/4/1949.html" title="1949">1949</a> Abbott introduces 74 new products in a single year, including pharmaceuticals, medical devices, and improved variations of existing products.</li>
<li><a href="../../../1/9/5/1950.html" title="1950">1950</a> Raymond E. Horn steps down as president because of illness. His successor is Dr. Ernest Volwiler, the first president since Dr. Burdick with a scientific background. Abbott introduces Sucaryl, its first truly consumer product, opens a registered entity in France, and enters into business in Spain.</li>
<li><a href="../../../1/9/5/1951.html" title="1951">1951</a> Abbott introduces Selsun Suspension shampoo for dandruff control. The company establishes an employee contributory stock purchase plan.</li>
<li><a href="../../../1/9/5/1952.html" title="1952">1952</a> Abbott introduces Erythrocin, a new antibiotic with good activity against gram-positive bacteria.</li>
<li><a href="../../../1/9/5/1953.html" title="1953">1953</a> Abbott's radiopharmaceutical business introduces Radiocaps, capsules containing an accurately controlled, invisible and un-weighable film of radioiodine that simplifies the diagnosis and treatment of thyroid disorders.</li>
<li><a href="../../../1/9/5/1959.html" title="1959">1959</a> Abbott introduces a new logo, which features a stylized “a” symbol that is still in use today.</li>
<li><a href="../../../1/9/6/1962.html" title="1962">1962</a> Abbott enters a joint venture with Dainippon Pharmaceuticals Co., Ltd., of Japan to manufacture radiopharmaceuticals. This venture will become Dainabot, and eventually evolve into Abbott Japan, the company’s largest operation outside the United States.</li>
<li><a href="../../../1/9/6/1963.html" title="1963">1963</a> The Triosorb diagnostic test kit, even simpler than the Radiocaps introduced ten years earlier, no longer requires a patient to swallow a radioactive substance; rather, a blood sample is inoculated with a radioactive form of thyroid hormone.</li>
<li><a href="../../../1/9/6/1964.html" title="1964">1964</a> Abbott acquires M&amp;R Dietetic Laboratories of Columbus, Ohio, best known as makers of Similac infant formula, one of the first milk-based infant formulas. M&amp;R eventually becomes Abbott’s Ross Products Division.</li>
<li><a href="../../../1/9/6/1965.html" title="1965">1965</a> Abbott’s growth warrants expansion at its headquarters location, and the company begins to move some operations to Abbott Park, a 420-acre site southwest of its North Chicago operations.</li>
<li><a href="../../../1/9/7/1972.html" title="1972">1972</a> Abbott introduces Tranxene, a tranquilizer, Ausria, a radioimmunoassay test to detect serum hepatitis, and the ABA-100 blood chemistry analyzer.</li>
<li><a href="../../../1/9/7/1973.html" title="1973">1973</a> Abbott forms a diagnostics division to bring together all diagnostic products and services. The company also introduces Ensure, the first adult medical nutritional.</li>
<li><a href="../../../1/9/7/1977.html" title="1977">1977</a> <a href="../../../t/a/p/TAP_Pharmaceuticals_22d5.html" title="TAP Pharmaceuticals">TAP Pharmaceuticals</a>, now known as TAP Pharmaceutical Products Inc., is formed as a joint venture between Abbott and Takeda Chemical Industries, Ltd. of Japan.</li>
<li><a href="../../../1/9/8/1981.html" title="1981">1981</a> Abbott introduces the TDx therapeutic drug monitoring system.</li>
<li><a href="../../../1/9/8/1983.html" title="1983">1983</a> Depakote (divalproex sodium) is approved in the United States.</li>
<li><a href="../../../1/9/8/1985.html" title="1985">1985</a> Abbott wins U.S. approval to market the world’s first diagnostic test for AIDS. Abbott also launches ADD-Vantage, an intravenous drug delivery system, and TAP receives its first product approval for Lupron (leuprolide acetate).</li>
<li><a href="../../../1/9/8/1987.html" title="1987">1987</a> Hytrin (terazosin hydrochloride) receives U.S. FDA approval.</li>
<li><a href="../../../1/9/8/1988.html" title="1988">1988</a> Abbott celebrates its centennial. The IMx diagnostic instrument, used in medium-sized laboratories, is introduced and will become the world’s leading immunoassay system and one of the best-selling new products in Abbott’s history.</li>
<li><a href="../../../1/9/9/1990.html" title="1990">1990</a> Clarithromycin launched. Clarithromycin is known as Biaxin in the United States and Klacid and Klaricid in countries around the world.</li>
<li><a href="../../../1/9/9/1991.html" title="1991">1991</a> Several major products are introduced worldwide, including Survanta (beractant) and a prostate-specific antigen (PSA) test to screen and monitor therapy for prostate cancer. Abbott enters the hematology testing market with the acquisition of Sequoia-Turner Corp.</li>
<li><a href="../../../1/9/9/1993.html" title="1993">1993</a> Abbott launches AxSYM, a new labor-saving diagnostic system.</li>
<li><a href="../../../1/9/9/1994.html" title="1994">1994</a> Abbott introduces sevoflurane, and completes an agreement to cross-license LCR and PCR, two gene amplification technologies.</li>
<li><a href="../../../1/9/9/1995.html" title="1995">1995</a> TAP receives approval for PREVACID (lansoprazole). In diagnostics, ABBOTT PRISM, the first, fully automated high-volume blood analyzer is introduced. Today, the ABBOTT PRISM is used to screen the majority of the world’s donated blood supply.</li>
<li><a href="../../../1/9/9/1996.html" title="1996">1996</a> Abbott launches Norvir (ritonovir). The company enters the glucose testing market with the acquisition of MediSense, Inc.</li>
<li><a href="../../../1/9/9/1997.html" title="1997">1997</a> After extensive research, Abbott’s Ross Products Division launches an improved version of Similac called Similac Advance.</li>
<li><a href="../../../1/9/9/1998.html" title="1998">1998</a> Abbott launches Glucerna shakes and snack bars, specially formulated nutritional products for people with diabetes. The U.S. FDA approves several major products including TriCor (fenofibrate) and Zemplar (paricalcitol).</li>
<li><a href="../../../1/9/9/1999.html" title="1999">1999</a> Abbott launches ARCHITECT, a next-generation diagnostic system. Abbott acquires Perclose, Inc., the leading arterial closure device manufacturer, which provides the foundation for building its vascular business. Later that year, the FDA approves The Closer, a next generation vascular closure device.</li>
<li><a href="../../../2/0/0/2000.html" title="2000">2000</a> Abbott receives approval for several new drugs and line extensions, including Kaletra (lopinavir/ritonavir), Biaxin XL (clarithromycin extended-release tablets), and Depakote ER (divalproex extended-release tablets). Abbott introduces an innovative award-winning, 32-ounce, reclosable plastic bottle for Similac with Iron.</li>
<li><a href="../../../2/0/0/2001.html" title="2001">2001</a> Abbott acquires the pharmaceutical business of BASF AG, including the global operations of Knoll Pharmaceuticals. In addition, Abbott acquires Vysis, Inc., and receives clearance to market the Vysis UroVysion test to monitor for recurrent bladder cancer.</li>
<li><a href="../../../2/0/0/2002.html" title="2002">2002</a> Abbott receives FDA approval for Humira (adalimumab). The company launches Similac Advance, Isomil Advance and NeoSure Advance infant formulas in the United States. Abbott acquires the cardiovascular stent business of Biocompatibles International plc., as it works to build its vascular business.</li>
<li><a href="../../../2/0/0/2003.html" title="2003">2003</a> Abbott launches HUMIRA in Europe. The company launches three new immunodiagnostics systems for use on the ARCHITECT platform. Abbott also continues to build its medical products business through several strategic acquisitions: JOMED's coronary and peripheral intervention business lines and Integrated Vascular Systems Inc.; Spinal Concepts Inc., an innovator of spinal implant devices; and ZonePerfect Nutritional Co., which signals Abbott's entrance into the fast-growing healthy living category of the nutrition market.</li>
<li><a href="../../../2/0/0/2004.html" title="2004">2004</a> Abbott acquires TheraSense Inc., a leading blood glucose monitoring business, to complement its fast-growing diabetes care business. The company also enters the point of care diagnostics market with the acquisition of i-STAT Corp.; adds to its healthy living nutrition offerings with the acquisition of EAS Inc., and firmly establishes its presence in the spinal device market with the acquisition of Spine Next S.A. Abbott also spins off its hospital products business as Hospira, an independent, publicly traded company. Hospira is one of the largest <a href="http://www.ebloggy.com/blog.php?username=buy&amp;id=1" class="external text" title="http://www.ebloggy.com/blog.php?username=buy&amp;id=1" rel="nofollow">global specialty pharmaceutical</a> and medication delivery companies serving the hospital.</li>
<li><a href="../../../2/0/0/2005.html" title="2005">2005</a> Abbott introduces several medical devices including the Xact carotid stent with the Emboshield capture device; the FreeStyle Connect blood glucose monitor; and, in the United States, launches the ABBOTT PRISM blood screening system and the CELL-DYN Sapphire hematology system. The company also receives FDA approval for two new uses for HUMIRA. Abbott also makes changes to its Kaletra product.</li>
<li><a href="../../../2/0/0/2006.html" title="2006">2006</a> Abbott acquires <a href="../../../g/u/i/Guidant.html" title="Guidant">Guidant</a>'s vascular business, which, combined with Abbott's ongoing business, creates one of the leading global vascular device companies. <a href="../../../i/n/t/Intermountain_Health_Care_ff05.html" title="Intermountain Health Care">Intermountain Health Care</a> switches its supported brand of glucometer for its roughly 2,000,000 patients to the new Freestyle Freedom and Freestyle Flash.</li>
<li><a href="../../../2/0/0/2006.html" title="2006">2006</a> Abbott acquires Kos Pharmaceuticals for a reported $3.6 billion</li>
<li><a href="../../../2/0/0/2007.html" title="2007">2007</a> Abbott agrees to divest its in vitro diagnostics and point-of-care diagnostics business units to the <a href="../../../g/e/_/GE_Healthcare_cb87.html" title="GE Healthcare">GE Healthcare</a> unit of <a href="../../../g/e/n/General_Electric_4bb6.html" title="General Electric">General Electric</a>.</li>
</ul>
<p><a name="Awards" id="Awards"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: Awards">edit</a>]</span> <span class="mw-headline">Awards</span></h2>
<div class="messagebox cleanup metadata">
<table style="width:100%;background:none">
<tr>
<td width="60px"><a href="../../../i/n/f/Image%7EInformation_icon.svg_dac9.html" class="image" title=""><img src="../../../upload/thumb/3/35/Information_icon.svg/40px-Information_icon.svg.png" alt="" width="40" height="40" longdesc="../../../i/n/f/Image%7EInformation_icon.svg_dac9.html" /></a></td>
<td><b>This article or section may require <a href="../../../h/o/w/Wikipedia%7EHow_to_structure_the_content_dc87.html" title="Wikipedia:How to structure the content">restructuring</a> to meet Wikipedia's <a href="../../../w/i/k/Category%7EWikipedia_style_guidelines_945d.html" title="Category:Wikipedia style guidelines">quality standards</a>.</b><br />
<small>Please discuss this issue on the <a href="../../../a/b/b/Talk%7EAbbott_Laboratories_8a06.html" title="Talk:Abbott Laboratories">talk page</a>. This article has been tagged since <b>January 2007</b>.</small></td>
</tr>
</table>
</div>
<p>Abbott is one of the 100 Best (US) Companies for Working Mothers in 2004 according to <a href="../../../w/o/r/Working_Mothers_7bc8.html" title="Working Mothers">Working Mothers</a> magazine.</p>
<p>Abbott has been repeatedly honored by FORTUNE magazine as one of the best companies in the country for its diversity practices and initiatives, including six straight years since the publication began its “50 Best Companies For Asians, Blacks and Hispanics” rankings.</p>
<p>Abbott was selected as one of “10 Best Companies for Women” by Health magazine in 2002. Abbott is both the only health care company on the list and the only company headquartered in Illinois. Those on the list are recognized for excelling in helping women balance their work and personal lives.</p>
<p>Abbott ranked #13 in Black Collegian magazine’s Top 50 Diversity Employers Survey in 2002 - and first among all pharmaceutical companies.</p>
<p>Abbott was named to Next Step’s Diversity 100: America’s Most Diverse Corporations by Next Step magazine in 2001.</p>
<p>Abbott was listed as one of the "25 Best Companies to Work for in Chicago" by Chicago Magazine.</p>
<p>Abbott received Five-star ratings in all internship program categories (selectivity, compensation, and quality of life) by Princeton Review’s America’s Top Internships.</p>
<p>Abbott named among "Science magazine's 2005 Top Employers." Science Magazine</p>
<p>Number 11 of the Top 50 Pharma Companies Pharmaceutical Executive (2004) For more information about this award, visit Pharm Exec 50 Special Report</p>
<p>Number 48 among the Top 500 American Companies Forbes magazine (2003)</p>
<p>Named No. 42 on the Business Week 50 as one of America's Best Companies BusinessWeek (2003)</p>
<p>Named one of America's Most Admired Companies every year since 1984 Fortune magazine</p>
<p>Named to the Barron's 500 Barron's, The Dow Jones Business and Financial Weekly (2002)</p>
<p>Number 157 among the Forbes Platinum 400 Forbes magazine (2002)</p>
<p>Number 21 among America's Best Wealth Creators Fortune magazine (2002)</p>
<p>Named to the Salomon Smith Barney 2001-2002 TEN+List Salomon Smith Barney (2002)</p>
<p>Number 93 among the 500 Largest U.S.-Based Corporations Number 285 among the Global 500 Fortune magazine (2005)</p>
<p>Abbott has a tradition of addressing <a href="../../../g/l/o/Global_citizenship.html" title="Global citizenship">global citizenship</a> issues. In 2005, Abbott and the Abbott Fund contributed more than $300 million in cash and product donations.<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since March 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p><br /></p>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/b/Abbott_Laboratories_de1d.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.abbott.gr/" class="external text" title="http://www.abbott.gr/" rel="nofollow">Abbott Hellas</a></li>
<li><a href="http://www.pharmaceutical-business-review.com/companyprofile.asp?guid=43227671-2079-49CF-A188-287DAE6EB406" class="external text" title="http://www.pharmaceutical-business-review.com/companyprofile.asp?guid=43227671-2079-49CF-A188-287DAE6EB406" rel="nofollow">Abbott Labs company profile and news archive</a></li>
<li><a href="http://www.washingtonpost.com/wp-dyn/articles/A40430-2004Aug4.html" class="external text" title="http://www.washingtonpost.com/wp-dyn/articles/A40430-2004Aug4.html" rel="nofollow">NIH Won't Intervene in AIDS Drug Pricing Issue</a>, <a href="../../../t/h/e/The_Washington_Post_5b91.html" title="The Washington Post">The Washington Post</a>, August 4, 2004</li>
</ul>

<!-- 
Pre-expand include size: 8735 bytes
Post-expand include size: 4357 bytes
Template argument size: 1264 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/b/b/Abbott_Laboratories_de1d.html">http://en.wikipedia.org../../../a/b/b/Abbott_Laboratories_de1d.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_listed_on_the_New_York_Stock_Exchange_e75b.html" title="Category:Companies listed on the New York Stock Exchange">Companies listed on the New York Stock Exchange</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_March_2007_2536.html" title="Category:Articles with unsourced statements since March 2007">Articles with unsourced statements since March 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../c/l/e/Category%7ECleanup_from_January_2007_fd48.html" title="Category:Cleanup from January 2007">Cleanup from January 2007</a></span> | <span dir='ltr'><a href="../../../b/i/o/Category%7EBiotechnology_companies_ac7f.html" title="Category:Biotechnology companies">Biotechnology companies</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_based_in_Illinois_cf25.html" title="Category:Companies based in Illinois">Companies based in Illinois</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_listed_on_NASDAQ_e0fd.html" title="Category:Companies listed on NASDAQ">Companies listed on NASDAQ</a></span> | <span dir='ltr'><a href="../../../m/u/l/Category%7EMultinational_companies_3122.html" title="Category:Multinational companies">Multinational companies</a></span> | <span dir='ltr'><a href="../../../p/h/a/Category%7EPharmaceutical_companies_of_the_United_States_4292.html" title="Category:Pharmaceutical companies of the United States">Pharmaceutical companies of the United States</a></span> | <span dir='ltr'><a href="../../../v/e/t/Category%7EVeterinary_medicine_companies_1fc1.html" title="Category:Veterinary medicine companies">Veterinary medicine companies</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_established_in_1888_f903.html" title="Category:Companies established in 1888">Companies established in 1888</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/b/b/Abbott_Laboratories_de1d.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/b/b/Talk%7EAbbott_Laboratories_8a06.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Abbott_Laboratories">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/b/b/Abbott_Laboratories_de1d.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/a/b/b/Abbott_Laboratories_de1d.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/a/b/b/Abbott_Laboratories_de1d.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B9%81/%E0%B8%AD/%E0%B8%9A/%E0%B9%81%E0%B8%AD%E0%B8%9A%E0%B8%9A%E0%B8%AD%E0%B8%95%E0%B8%95%E0%B9%8C.html">ไทย</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 21:16, 29 March 2007 by Wikipedia user <a href="../../../n/o/t/User%7ENotinasnaid_e8da.html" title="User:Notinasnaid">Notinasnaid</a>. Based on work by Wikipedia user(s) <a href="../../../a/m/c/User%7EAmcl_e8c7.html" title="User:Amcl">Amcl</a>, <a href="../../../t/h/e/User%7EThe_wub_6388.html" title="User:The wub">The wub</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../s/t/r/User%7EStrainul_9229.html" title="User:Strainul">Strainul</a>, Devinship, Latash, <a href="../../../n/3/2/User%7EN328KF_2ea6.html" title="User:N328KF">N328KF</a>, <a href="../../../p/i/e/User%7EPierpontpaul2351_6571.html" title="User:Pierpontpaul2351">Pierpontpaul2351</a>, <a href="../../../o/m/b/User%7EOmbudsman_aae9.html" title="User:Ombudsman">Ombudsman</a>, <a href="../../../h/r/a/User%7EHraefen_512a.html" title="User:Hraefen">Hraefen</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../t/h/e/User%7EThe_Rambling_Man_48d1.html" title="User:The Rambling Man">The Rambling Man</a>, <a href="../../../s/h/a/User%7EShawnc_13f4.html" title="User:Shawnc">Shawnc</a>, <a href="../../../w/i/l/User%7EWildball_f29b.html" title="User:Wildball">Wildball</a>, <a href="../../../a/l/v/User%7EAlvestrand_d574.html" title="User:Alvestrand">Alvestrand</a>, <a href="../../../a/m/e/User%7EAmerika_199f.html" title="User:Amerika">Amerika</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, Reggie Bush and Manwich sitting in a tree, <a href="../../../p/e/r/User%7EPeripatetic_b918.html" title="User:Peripatetic">Peripatetic</a>, Robbyyy, <a href="../../../g/r/e/User%7EGreenshed_5a67.html" title="User:Greenshed">Greenshed</a>, <a href="../../../d/r/a/User%7EDralwik_97c6.html" title="User:Dralwik">Dralwik</a>, <a href="../../../r/o/x/User%7ERoxbury-de_44c5.html" title="User:Roxbury-de">Roxbury-de</a>, <a href="../../../b/o/v/User%7EBovineone_f416.html" title="User:Bovineone">Bovineone</a>, <a href="../../../d/e/l/User%7EDeli_nk_ed07.html" title="User:Deli nk">Deli nk</a>, <a href="../../../s/l/o/User%7ESlo-mo_9dec.html" title="User:Slo-mo">Slo-mo</a>, <a href="../../../j/o/e/User%7EJoe_Decker_f7b7.html" title="User:Joe Decker">Joe Decker</a>, <a href="../../../h/a/r/User%7EHarryboyles_b16b.html" title="User:Harryboyles">Harryboyles</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, Medicine7, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../t/a/w/User%7ETawkerbot2_313a.html" title="User:Tawkerbot2">Tawkerbot2</a>, <a href="../../../b/r/a/User%7EBrabblebrex_f9b5.html" title="User:Brabblebrex">Brabblebrex</a>, <a href="../../../t/h/e/User%7EThepangelinanpost_f801.html" title="User:Thepangelinanpost">Thepangelinanpost</a>, Kinostx, <a href="../../../c/a/t/User%7ECatapult_5a86.html" title="User:Catapult">Catapult</a>, <a href="../../../w/o/r/User%7EWorldtravller_b5cf.html" title="User:Worldtravller">Worldtravller</a>, <a href="../../../b/r/a/User%7EBrainhell_3ced.html" title="User:Brainhell">Brainhell</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../m/a/l/User%7EMalepheasant_b77c.html" title="User:Malepheasant">Malepheasant</a>, <a href="../../../k/b/d/User%7EKbdank71_f952.html" title="User:Kbdank71">Kbdank71</a>, <a href="../../../b/l/u/User%7EBluemoose_d309.html" title="User:Bluemoose">Bluemoose</a>, <a href="../../../i/a/n/User%7EIan_Pitchford_f7f8.html" title="User:Ian Pitchford">Ian Pitchford</a>, <a href="../../../w/h/o/User%7EWhobot_b6b5.html" title="User:Whobot">Whobot</a>, <a href="../../../a/e/c/User%7EAecis_7d64.html" title="User:Aecis">Aecis</a>, <a href="../../../f/u/n/User%7EFunc_268d.html" title="User:Func">Func</a>, <a href="../../../e/d/c/User%7EEdcolins_06ae.html" title="User:Edcolins">Edcolins</a>, <a href="../../../i/k/e/User%7EIkescs_6a7a.html" title="User:Ikescs">Ikescs</a>, <a href="../../../j/o/h/User%7EJohn_Kenney_4b6b.html" title="User:John Kenney">John Kenney</a>, Ibpassociation, Mirth, <a href="../../../v/a/r/User%7EVariable_3b71.html" title="User:Variable">Variable</a>, <a href="../../../b/o/o/User%7EBoothy443_59af.html" title="User:Boothy443">Boothy443</a>, <a href="../../../s/p/a/User%7ESpangineer_57d1.html" title="User:Spangineer">Spangineer</a>, <a href="../../../a/l/i/User%7EAlison9_d6d0.html" title="User:Alison9">Alison9</a>, <a href="../../../s/o/r/User%7ESortior_5b11.html" title="User:Sortior">Sortior</a>, <a href="../../../t/i/m/User%7ETimo_Honkasalo_9467.html" title="User:Timo Honkasalo">Timo Honkasalo</a>, <a href="../../../k/w/e/User%7EKwertii_f6e2.html" title="User:Kwertii">Kwertii</a>, <a href="../../../d/y/s/User%7EDysprosia_bc6d.html" title="User:Dysprosia">Dysprosia</a>, <a href="../../../a/n/t/User%7EAnthony_DiPierro_ebfd.html" title="User:Anthony DiPierro">Anthony DiPierro</a> and <a href="../../../a/v/e/User%7EAverage_Earthman_c2cf.html" title="User:Average Earthman">Average Earthman</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
